Abstract
BackgroundLung cancer is the leading cause of cancer-related deaths worldwide. The advent of ICIs specifically targeting programmed cell death protein-1 (PD-1), or its ligand (PD-L1) represents a major therapeutic advance...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have